Adoptive Immunotherapy

Adoptive Immunotherapy is a form of immunotherapy that involves the transfer of ex vivo activated or selected immune cells, typically T lymphocytes, into a recipient to mediate specific immune responses against diseased cells, particularly in the context of malignancy or persistent infection.

1.7K

Publications

137.7K

Citations

10K

Authors

1.9K

Institutions

Publications per year

2017–2026

386

Authors

10K

  1. SA
    Steven A. Rosenberg

    National Cancer Institute, United States

    73 publications · 22.1K citations

    51

    h-index

  2. AE
    Alfred E. Chang

    University of Michigan, United States

    38 publications · 5.2K citations

    27

    h-index

  3. NP
    Nicholas P. Restifo

    National Cancer Institute, United States

    25 publications · 9.8K citations

    25

    h-index

  4. SS
    Suyu Shu

    Cleveland Clinic, United States

    25 publications · 2.2K citations

    23

    h-index

  5. PD
    Philip D. Greenberg

    University of Washington, United States

    25 publications · 5.5K citations

    23

    h-index

1–5 of 10K

Venues

  1. The Journal of Immunology

    JI · 113 publications · 11K citations

    60

    h-index

  2. PubMed

    Repository · 186 publications · 8.2K citations

    49

    h-index

  3. Journal of Immunotherapy

    83 publications · 6.2K citations

    41

    h-index

  4. Blood

    52 publications · 9.8K citations

    41

    h-index

  5. Cancer Research

    50 publications · 5.3K citations

    34

    h-index

1–5